“Magnetic resonance imaging (MRI) biomarkers are vital for multiple sclerosis (MS) clinical research and trials but quantifying them requires multi-contrast protocols and limits the use of ...

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed.

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers.

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL Queen Square Institute of ...

We introduce a multiscale approach that combines segmentation with classification to detect abnormal brain structures in medical imagery, and demonstrate its utility in automatically detecting ...

WEST PALM BEACH, Fla. — Ocrelizumab significantly reduced the number and volume of cortical lesions associated with multiple sclerosis at 120 weeks, findings confirmed by data from a series ...

Background A growing arsenal of treatment options for relapsing multiple sclerosis (RMS) emphasises the need for early prognostic biomarkers. While evidence for individual markers exists, ...

Figure 1. FLAIR sequence. Perivenular hyperintensities (Dawson's fingers) representing demyelination and characteristic of multiple sclerosis. FLAIR = Fluid attenuated inversion recovery.

The FDA cleared an extended version of Neurophet AQUA that uses AI for analysis in counting and measuring MS brain lesions on MRI scans.

Access free, up-to-date clinical references for comprehensive information on assessing multiple sclerosis at Healio. Our content provides valuable insights for physicians.

Patients with suspected multiple sclerosis can be accurately evaluated and diagnosed using a simplified central vein sign assessment method in combination with the McDonald Criteria.